, by members of a preferred provider organization. 
). For the second analysis, the selected medications' were grouped into therapeutic drug classes (see Table 1 ). Table 2 ). The overall analysis was found to contain statistically significant differences between the MPRs of indi- 11 of the 14 significant differences found between medications involved conjugated estrogens leads us to conclude that while the analysis was found to contain significant differences, few pairwise comparisons were found to be statistically significant. 
Although

